Originally published In Press as doi:10.1074/jbc.M201093200 on March 13, 2002
J. Biol. Chem., Vol. 277, Issue 22, 19688-19696, May 31, 2002
Nuclear Localization Signal of Murine CMP-Neu5Ac
Synthetase Includes Residues Required for Both Nuclear Targeting and
Enzymatic Activity*
Anja-K.
Münster
,
Birgit
Weinhold
,
Birgit
Gotza
,
Martina
Mühlenhoff
,
Matthias
Frosch§, and
Rita
Gerardy-Schahn
¶
From the
Institut für Physiologische
Chemie/Proteinstruktur, Medizinische Hochschule Hannover,
Carl-Neuberg-Strasse 1, 30625 Hannover, Germany and the
§ Institut für Hygiene und Mikrobiologie,
Universität Würzburg, Josef-Schneider-Strasse 2, 97080 Würzburg, Germany
Received for publication, February 1, 2002, and in revised form, March 11, 2002
 |
ABSTRACT |
5-N-Acetylneuraminic acid (Neu5Ac) is
the major sialic acid derivative found in animal cells. As a component
of cell surface glycoconjugates, Neu5Ac is pivotal to numerous cellular
recognition and communication processes including host-parasite
interactions. A prerequisite for the synthesis of sialylated
glycoconjugates is the activation of Neu5Ac to cytidine-monophosphate
N-acetylneuraminic acid (CMP-Neu5Ac). The reaction is
catalyzed by CMP-Neu5Ac-synthetase (syn), which, for unknown reasons,
resides in the nucleus. Sequence analysis of the cloned murine
CMP-Neu5Ac synthetase identified three clusters of basic amino acids
(BC1-BC3) that might function as nuclear localization signals (NLS).
In the present study chimeric protein and mutagenesis strategies were
used to show that BC1 and BC2 are active NLS sequences when attached to
the green fluorescent protein (enhanced GFP), but only BC2 is necessary
and sufficient to mediate the nuclear import of CMP-Neu5Ac synthetase.
Site-directed mutations identified the residues
K198RXR to be essential for nuclear
transport and Arg202 to be necessary to complete the
transport process. Cytoplasmic forms of CMP-Neu5Ac synthetase generated
by single site mutations in BC2 demonstrated that (i) enzyme activity
is independent of nuclear localization, and (ii) Arg199 and
Arg202 are involved in both nuclear transport and
synthetase activity. Comparison of all known and predicted CMP-sialic
acid synthetases reveals Arg202 and Gln203 as
highly conserved in evolution and critically important for optimal
synthetase activity but not for nuclear localization. Combined, the
data demonstrate that nuclear transport and enzyme activity are
independent functions that share some common amino acid requirements in
CMP-Neu5Ac synthetase.
 |
INTRODUCTION |
Sialic acids acids are a family of negatively charged, 9-carbon
sugars that form terminal residues on cell surface glycoproteins and
glycolipids and provide the bulk of the negative charge, which is
characteristic for animal cell surfaces (for review, see Ref. 1). More
than 40 sialic acid derivatives have been identified in biological
systems. The most abundant form in higher vertebrates is
5-N-acetylneuraminic acid
(Neu5Ac).1 Sialic acids play
important roles in cell-cell communication and recognition processes
and mediate immune responses by binding to selectins and other members
of the SIGLEC family (for review, see Refs. 2 and 3). Moreover, vital
processes such as fertilization (for review, see Ref. 4), neural cell
growth, differentiation and plasticity (for review, see Refs. 5 and 6;
Ref. 7), biological aging (8), as well as development (6, 9) and progression of malignancies (10-12) are accompanied by alterations in
the cellular sialylation pattern. In bacteria sialic acids are found as
components of capsules and lipooligosaccharides and often are important
virulence factors, mediating resistance to host defense mechanisms
(reviewed in Refs. 13-15). For example, Neisseria
meningitidis serogroup B (NmB), the major cause of
meningitis outbreaks in the western hemisphere, expresses a capsular
polysaccaride consisting of
2,8-linked sialic acid residues,
exclusively. The polysialic acid (polySia) of the NmB
capsule is identical to host expressed polySia, which represents a
specific posttranslational modification of the neural cell adhesion
molecule (for review, see Ref. 16). This classical example of
antigenic mimicry explains the low serum response caused by
NmB in infected individuals (17).
A prerequisite for the incorporation of sialic acids into
glycoconjugates is their activation as cytidine-monophosphate diester (CMP-Neu5Ac). This reaction is catalyzed by the
CMP-N-acetylneuraminic acid synthetase (CMP-Neu5Ac-syn, EC
2.7.7.43; for review, see Ref. 18). The nucleotide sequences of six
bacterial (19-24) and two vertebrate CMP-sialic acid-syn (25, 26) are
available. The alignment of the deduced protein sequences revealed five
highly conserved motifs indicating a common ancestor (25, 26). Thus the
CMP-sialic acid synthetases provide the first example for an
evolutionary conservation from bacteria to vertebrates among the sialic
acid metabolizing enzymes.
The first vertebrate CMP-Neu5Ac-syn cDNA was isolated by
complementation cloning in the Chinese hamster ovary (CHO) mutant LEC29.Lec32, which due to the lec32 mutation does not
contain an active CMP-Neu5Ac-syn. These cells cannot transfer the
non-activated sugar onto glycoconjugates and therefore lack sialic acid
and polySia on the cell surface. Expression cloning with polySia
detection as an assay of complementation led to the isolation of a
mouse CMP-Neu5Ac-syn cDNA (25). Analysis of the intracellular
localization of the recombinant murine CMP-Neu5Ac synthetase confirmed
earlier studies that showed the majority of CMP-Neu5Ac-syn activity to be localized in the nuclear compartment (for review, see Ref. 18). This
is in clear contrast to all other nucleotide sugar synthetases, which
are restricted to the cytoplasm. The unusual localization of the
CMP-Neu5Ac-syn has been a focus of scientific interest for more than 30 years but still remains an enigma (for review, see Refs. 18 and
25).
While small molecules and proteins are able to enter the nucleus by
passive diffusion, the import of larger proteins through the nuclear
pore complex is mediated by active transport. The nuclear import
machinery is complex and various pathways are used simultaneously to
achieve the import of many different substrates (for review, see Refs.
27-29). Most karyophilic proteins contain one or more nuclear
localization signals (NLS) that are recognized by soluble factors of
the nuclear transport system (for review, see Ref. 30). NLS motifs are
non-cleaved signal sequences within a protein that do not fit a tight
consensus motif. The so called classical or canonical NLS typically
consists of one or more clusters of basic amino acids often preceded by
a proline residue (for review, see Refs. 27, 31, and 32). One of the
best defined NLSs is located in the simian virus SV40 large T (SV40-T)
antigen (P126KKKRKV; Ref. 33). In the murine CMP-Neu5Ac-syn
three potential NLSs termed basic clusters (BCs) 1, 2, and 3 are
present, and their involvement in nuclear transport has been proposed
earlier (25).
In the present study, wild-type and mutant sequences of BC1, BC2, and
BC3 were tested for their ability to transport eGFP chimeras and
CMP-Neu5Ac-syn to the nuclear compartment. In addition, the enzymatic
activity of the generated CMP-Neu5Ac-syn mutants was analyzed. The data
provide clear evidence that (i) functional activity of CMP-Neu5Ac-syn
is not dependent on nuclear localization, and (ii) some mutations that
prevent nuclear localization also reduce or eliminate synthetase activity.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Endoneuraminidase NE (endoNE) specifically
degrades
-2,8-linked polySia. The enzyme was purified from the
Escherichia coli K1 bacteriophage, PK1E, as described
previously (34). Monoclonal antibody (mAb) 735 directed against
-2,8-linked polySia (35) was used after purification on protein
A-Sepharose (Amersham Biosciences). Anti-FLAG mAb M5 directed
against the FLAG epitope (MDYKDDDDK) was purchased from Sigma.
Expression Plasmids--
The eukaryotic expression plasmid pAM22
consists of full-length murine CMP-Neu5Ac-syn cDNA with N-terminal
FLAG- and Myc-tag (EQKLISEEDL) in a pcDNA3 vector (Invitrogen). For
prokaryotic expression the N-terminally FLAG/Myc-tagged murine
CMP-Neu5Ac-syn cDNA was subcloned into the vector pTrc99A (Amersham
Biosciences), resulting in plasmid pTrAM22. The plasmid pTrFMNmBsyn
consists of full-length N-terminally FLAG/Myc-tagged NmB
CMP-Neu5Ac-syn DNA in pTrc99A (Amersham Biosciences).
Plasmids for eukaryotic expression of C-terminally extended eGFP fusion
proteins were generated by the use of the eukaryotic expression vector
peGFPCI (CLONTECH). Sense and antisense
oligonucleotides that encode BC1, BC2, and BC3 of murine CMP-Neu5Ac-syn
or the SV40-T NLS were synthesized. Oligonucleotides were generated
with overhanging sequences to allow for the directed cloning into
BglII and EcoRI restriction sites as shown in
Table I. Matching oligonucleotide pairs were annealed and ligated into
the BglII and EcoRI sites of peGFPCI, resulting
in 3'-extended eGFP cDNAs. The integrity of all plasmids was
confirmed by sequencing.
Construction of Mutants--
Site-directed mutations were
introduced using the QuikChangeTM site-directed mutagenesis
kit (Stratagene) according to the supplier's instructions, using
Pfu polymerase (Stratagene). Mutation primers were designed
to either delete nucleotide triplets encoding selected amino acids or
to replace natural triplets by GCN, which encodes alanine. Sequences of
the mutation primers together with the plasmid names are given in Table
II. The integrity of all N-terminally FLAG/Myc-tagged mutants was
confirmed by automated sequencing both, before and after subcloning.
Cell Culture--
CHO cells of the complementation group
LEC29.Lec32 (36) were cultured in
-MEM (Invitrogen). NIH 3T3
cells (ATCC CRL 1685) were maintained in Dulbecco's modified Eagle's
medium (Seromed). Both media were supplemented with 1 mM
sodium pyruvate and 10% fetal calf serum. Mammalian cells were
maintained in a humidified 5% CO2 atmosphere at
37 °C.
Expression of CMP-Neu5Ac-Syn--
The functionality of wild-type
and mutant murine CMP-Neu5Ac-syn was analyzed in complementation
studies using CHO LEC29.Lec32 (36) and E. coli EV5 (37). For
eukaryotic expression 1.8 × 106 LEC29.Lec32 cells
were grown overnight on 60-mm tissue culture dishes, rinsed twice with
PBS (10 mM sodium phosphate, pH 7.4, 150 mM
NaCl), and transiently transfected with 2 µg of plasmid DNA and 12 µl of LipofectAMINE (Invitrogen) in 2.5 ml of Opti-MEM (Invitrogen).
After 7 h transfections were stopped by adding 5 ml of medium
containing 10% fetal calf serum. After another 17 h the medium
was exchanged, and cells were harvested 48 h later. After washing
with PBS, transfected cells of one 60-mm-plate were subdivided into two
aliquots, and both aliquots were incubated for 30 min at 37 °C in
the absence or presence of 100 ng of endoNE to remove polySia.
Subsequently, the cells of both aliquots were lysed in 100 µl of
ice-cold lysis buffer (50 mM Tris-HCl, pH 8.0, 1 mM MnCl2, 1% Nonidet P-40, 200 units of
aprotinin and 1 mM phenylmethylsulfonyl fluoride),
sonicated (Branson Sonifier, 50% duty cycle, output control 5, 4 °C, 18 × 5 s), and centrifuged at 16,000 × g. The protein concentration of the supernatant was
determined using BCA protein assay reagent (Pierce). Lysates diluted to
a final concentration of 2.5 mg/ml in lysis buffer were analyzed by
SDS-PAGE (see below).
For prokaryotic expression E. coli EV5 were transformed with
10 ng of plasmid DNA. Bacteria were grown at 37 °C to an
A600 0.4, and protein expression was
induced with 0.2 mM
isopropyl-
-D-thiogalactoside for 2 h. Thereafter,
bacteria were harvested and washed with PBS. An aliquot was resuspended
in sonication buffer (PBS containing 200 units of aprotinin and 1 mM phenylmethylsulfonyl fluoride), and cells were
sonicated as described previously. After removal of cell debris,
the protein concentrations were determined using BCA protein assay
reagent (Pierce). Two parallel samples (bacteria corresponding to 200 µg of protein each) were incubated for 30 min at 37 °C in the
absence or presence of 100 ng of endoNE. The bacteria from these
parallel samples were pelleted, resuspended in 50 µl of PBS, mixed
1:1 with 2× Laemmli sample buffer, sonicated as described, and further
analyzed by SDS-PAGE as described below.
SDS-PAGE and Western Blot Analysis--
SDS-PAGE was performed
according to Laemmli (38). Samples were reduced with 2.5% (v/v)
-mercaptoethanol and heated at 65 °C for 20 min. After
electrophoretic separation proteins were blotted onto nitrocellulose
membranes (Schleicher & Schuell), and Western blots were developed
using 5 µg/ml of primary antibody followed by anti-mouse alkaline
phosphatase conjugate (Dianova). Nitro blue tetrazolium and
5-bromo-4-chloro-3-indoyl phosphate were used as substrates for
alkaline phosphatase.
Transfection of NIH 3T3 Cells and
Immunofluorescence--
Twenty-four h before transfection, 3 × 104 cells per well were seeded in 12-well plates containing
glass coverslips. Transient transfections were performed using the
Superfect transfection kit (Qiagen). In 20 µl of Dulbecco's modified
Eagle's medium, 0.4 µg of DNA were mixed with 2 µl of Superfect,
incubated at room temperature for 10 min, mixed with 500 µl complete
medium, and then added to the washed cells. Cells were carefully washed with PBS 24 h after transfection, fixed in 4% paraformaldehyde for 20 min, and washed twice with PBS. For indirect immunofluorescence staining, transfected cells were permeabilized with 0.2% Triton X-100
for 10 min at room temperature, washed with PBS, and incubated with the
anti-FLAG mAb M5 (3.5 µg/ml in 20% horse serum in PBS) for 1 h
at 37 °C. After washing with PBS, cells were incubated with sheep
anti-mouse IgG-Cy3 (Sigma; 1:300 in PBS containing 20% horse serum)
for 1 h at 37 °C. After three additional washes with PBS,
nuclei were stained with Hoechst 33258 (Hoechst Pharmaceuticals) at a
concentration of 500 ng/ml in PBS for 4 min at room temperature. Cells
transfected with the peGFPCI constructs (see Table I) were used for
direct immunofluorescence 24 h after transfection. Cells were
fixed in 4% paraformaldehyde and stained with Hoechst 33258 as described previously. All coverslips were mounted in Moviol and analyzed under a Zeiss Axiophot fluorescence microscope
(×400).
Computational Analysis--
PSORTII was performed for the
prediction of protein localization sites in cells (psort.nibb.ac.jp;
Refs. 39 and 40), and the method of Cokol (Ref. 41;
cubic.bioc.columbia.edu/predictNLS) was applied to search for putative
NLS.
 |
RESULTS |
Identification of Potential Nuclear Localization
Signals--
Murine CMP-Neu5Ac synthetase has been shown to reside in
the cell nucleus, and three clusters of basic amino acids have been identified that may function as NLS sequences (25). The locations and
amino acid sequences of the basic clusters (BC1, BC2, and BC3) are
shown in Fig. 1. NLS sequences are often
preceded by helix-breaking proline residues (for review, see Ref. 32).
Therefore, the sequences
K198RPRR2
(BC2) and P196AKRPRR (BC2PA) are both potential
NLS motifs and were investigated. The gray boxes in Fig. 1
indicate sequence motifs that are highly conserved between bacterial
and vertebrate CMP-Neu5Ac-syn, suggesting their importance for enzyme
structure and/or function. It should be noted that BC2 is surrounded by
highly conserved domains. Computational analyses, performed with
different algorithms as described under "Experimental Procedures,"
identified only BC2 as a potential NLS (program PSORTII; Refs. 39 and
40). BC1 and BC3 were determined by eye.

View larger version (8K):
[in this window]
[in a new window]
|
Fig. 1.
Schematic representation of murine
CMP-Neu5Ac-syn. The positions of BCs are shown as open
boxes with amino acid sequences given below. Two forms of BC2 used
in the subsequent experiments are shown, BC2 (K198RPRR) and
an N-terminal-extended form BC2PA (P196AKRPRR).
The five primary sequence motifs conserved in bacterial and vertebrate
CMP-sialic acid synthetases are shown as light gray
boxes.
|
|
Initial experiments investigated the ability of BC sequences to direct
a non-nuclear protein to the nuclear compartment. BC1, BC2,
BC2PA, and BC3 were fused to eGFP, which encodes a soluble
protein that distributes evenly throughout the cell (Ref. 42; Table I). The NLS (P126KKKRKV) of
simian virus SV40 large T antigen (SV40-T) was fused to eGFP as a
positive control (Ref. 33; Table I). eGFP and C-terminal-extended
eGFP-fusion proteins were transiently expressed in NIH 3T3 cells and
visualized by direct immunofluorescence microscopy (Fig.
2, panel 1). DNA staining with
Hoechst 33258 was used to detect cell nuclei (Fig. 2, panel
2). The merged images shown in Fig. 2, panel 3, clearly
demonstrate that eGFP without any fusion peptide is homogenously
distributed throughout the cell, while the eGFP-SV40-T chimera
localizes to the cell nucleus. Like eGFP-SV40-T the fusion proteins
eGFP-BC1, eGFP-BC2, and eGFP-BC2PA were found in the
nuclear compartment. In contrast, eGFP-BC3 mirrored the staining
obtained with eGFP. Therefore, BC1 and BC2/BC2PA, but not
BC3, are sufficient to target a non-nuclear protein to the cell
nucleus.
View this table:
[in this window]
[in a new window]
|
Table I
eGFP Fusion proteins
Plasmids for eukaryotic expression of eGFP fusion proteins were
generated by ligating hybridized oligonucleotides to the 3'-end of the
eGFP cDNA in the vector peGFPCI. This table shows the names of the
resulting plasmids (column 1) as well as the amino acid sequences of
the basic clusters (column 2) encoded by the corresponding
oligonucleotides (column 3). The oligonucleotides were generated with
overhanging sequences to allow for the directed cloning into
BglII and EcoRI sites of the vector
(BglII and EcoRI extensions are italicized).
Oligonucleotides were hybridized and ligated into the corresponding
restriction sites in peGFPCI. The NLS of the large T antigen of simian
virus SV40 (SV40-T) served as a positive
control.
|
|

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 2.
Intracellular localization of eGFP fusion
proteins. BCs of murine CMP-Neu5Ac-syn or SV40-T antigen
NLS were fused individually to the C terminus of eGFP (Table I). NIH
3T3 cells were transiently transfected with cDNAs of either eGFP
alone or eGFP fusion proteins. Intracellular localization was analyzed
by direct immunofluorescence at ×400 magnification (panel
1). Cell nuclei were stained with Hoechst 33258 (panel
2). The photos are merged in panel 3.
|
|
BC2 Is Necessary and Sufficient to Target Murine CMP-Neu5Ac-syn to
the Nucleus--
To determine the importance of BC1, BC2, and BC3 in
nuclear transport of murine CMP-Neu5Ac-syn itself, each motif was
individually deleted in an N-terminally FLAG/Myc-tagged enzyme giving
the constructs
BC1,
BC2,
BC2PA, and
BC3 (Table
IIA). Deletion mutants and wild-type
murine CMP-Neu5Ac-syn were expressed in NIH 3T3 cells, and the
intracellular localization of these proteins was analyzed by indirect
immunofluorescence microscopy using anti-FLAG mAb M5 and a Cy3-labeled
secondary antibody (Fig. 3, panel
1). Cell nuclei were stained with Hoechst 33258 (Fig. 3,
panel 2), and the merged photos are shown in panel 3. The data show that all mutant proteins were expressed. However, only
BC1 and
BC3 were efficiently transported to the cell
nucleus. Nuclear transport was abolished in mutants
BC2 and
BC2PA. Moreover, an insertion-mutant Ins-BC2,
in which K198RPRR is replaced by Q198DWDGNLNPA,
by chance found in mutagenesis experiments and used as an additional
control, was unable to enter the cell nucleus. These results confirm
BC2 as being the only essential NLS in CMP-Neu5Ac-syn. BC1, which
functions as an NLS for eGFP (Fig. 2), had no visible effect on the
nuclear transport of murine CMP-Neu5Ac-syn under the conditions used in
this study.
View this table:
[in this window]
[in a new window]
|
Table II
Mutants of CMP-Neu5Ac-Syn
BCs in the murine CMP-Neu5Ac-syn were deleted using the primers given
in A. In mutant Ins-BC2 the basic cluster 2 is replaced by a nonsense
insertion that occurred by chance during mutagenesis. Single amino
acids exchanges were introduced by site-directed mutagenesis using the
primers given in B for the murine enzyme and in C for the
NmB enzyme. The nucleotide triplet used for the selected
amino acid was changed to alanine (GCN) by the indicated nucleotide
exchanges (bold letters in the primer sequences). Deleted or exchanged
nucleotides are given in second column.
|
|

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 3.
Intracellular localization of murine
CMP-Neu5Ac-syn mutants lacking individual basic clusters
( BC). Wild-type and mutant
constructs were transiently expressed in NIH 3T3 cells. The mutant
Ins-BC2 harbors a ten-amino acid nonsense insertion
(Q198DWDGNLNPA) instead of wild-type sequence
(K198RPRR) at BC2. N-terminally FLAG/Myc-tagged
CMP-Neu5Ac-syn and the different mutant forms were localized by
immunostaining with anti-FLAG mAb M5 and a Cy3-conjugated secondary
antibody (panel 1). Nuclear staining was performed with
Hoechst 33258 (panel 2). The photos are merged in
panel 3 (×400 magnification).
|
|
All Basic Residues in BC2 Are Important for Nuclear
Targeting--
Next, the contribution of single amino acid residues in
BC2 for its function as an NLS was investigated. The sequence stretch P196AKRPRRQD containing BC2PA plus two
additional downstream residues was systematically modified by
site-directed mutagenesis. Amino acids were replaced by alanine, either
in pairs (mutants K198A/R201A and R199A/R202A) or individually (all other mutants, Table IIB). After transient expression in NIH 3T3
cells, the subcellular localization of mutant proteins was analyzed by
indirect immunofluorescence microscopy using the anti-FLAG mAb M5 and a
Cy3-labeled secondary antibody (Fig. 4, panel 1). Cell nuclei were stained with Hoechst 33258 (Fig.
4, panel 2), and images were merged in panel 3.
Simultaneous mutation of two basic amino acids trapped the proteins
K198A/R201A (Fig. 4A) and R199A/R202A (Fig. 4B)
in the cytoplasm. Moreover, individual replacement of the above
mentioned residues by alanine led to the expression of cytoplasmic
proteins in the case of K198A, R199A, and R201A (Fig. 4,
D-F). Only mutant R202A (Fig. 4G) was targeted to the nucleus, although a weak cytoplasmic staining was visible for
R202A in a subsequent set of experiments. In contrast, replacement of
Pro200 (P200A) and of the neighboring residues
Pro196, Gln203, and Asp204 by
alanine (P196A, Q203A, D204A) had no effect on nuclear transport (Fig.
4, H-K).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 4.
Intracellular localization of murine
CMP-Neu5Ac-syn mutants. Wild-type (A) and
mutant constructs (B-K) were transiently expressed in NIH
3T3 cells. To localize the FLAG/Myc-tagged proteins, permeabilized
cells were stained with anti-FLAG mAb M5. Bound primary antibodies were
visualized with anti-mouse IgG-Cy3 (panel 1). Nuclear
staining was performed with Hoechst 33258 (panel 2). The
photos are merged in panel 3 (×400 magnification). All
analyzed amino acid exchanges are located in the nine-amino acid
stretch given below. The sequence of BC2 is highlighted with a
gray box. Amino acids essential for nuclear transport are
marked with an asterisk.
|
|
Cytoplasmic Forms of Murine CMP-Neu5Ac-syn Are Catalytically
Active--
To determine whether nuclear localization is a
prerequisite for CMP-Neu5Ac synthetase activity in mammalian cells, the
enzymatic activity of nuclear- and cytoplasmic-localized CMP-Neu5Ac-syn mutants used in Figs. 3 and 4 was analyzed in vivo by
complementation of two cellular systems lacking active CMP-Neu5Ac-syn:
CHO cells of the complementation group LEC29.Lec32 (36) and E. coli strain EV5, a derivative of E. coli K1 (37). In
both mutants a genetic defect inactivates endogenous CMP-Neu5Ac-syn,
leading to an asialo-phenotype (36, 43). One sialic acid epitope
missing in both cellular systems is polySia, and cell lysates did not
bind the polySia-specific mAb 735 (see first lane (Ø) in
Fig. 5). However, after transfection with
wild-type murine CMP-Neu5Ac-syn a return to the polySia-positive phenotype was observed in LEC29.Lec32 cells as well as in E. coli EV5 (Fig. 5). Complementation of the polySia-negative
phenotype was used to test the activity of CMP-Neu5Ac-syn variants. The bacterial mutant served as a control, because defects influencing nuclear transport of CMP-Neu5Ac-syn would not be functionally relevant
in the prokaryotic system. EndoNE treatment of lysates to remove
polySia was used to show that mAb 735 is specific for the polySia
epitope (34). Parallel samples of the cell lysates were analyzed by
Western blot before (
) and after (+) treatment with endoNE (Fig. 5).
PolySia, which is bound to the neural cell adhesion molecule in
mammalian cells (16), migrates as a diffuse band above 200 kDa (Fig.
5A). In E. coli K1 polySia is bound to a lipid
anchor of yet unidentified structure (for review, see Ref. 44) and
migrates as a typical smear between 30 and 100 kDa (Fig.
5C). Mutant forms of N-terminally FLAG/Myc-tagged murine CMP-Neu5Ac-syn (see Fig. 5) were transiently expressed in LEC29.Lec32 and in E. coli EV5 cells, and re-expression of polySia was
monitored as described. Deletion mutants
BC1 and
BC3, which are
both targeted to the cell nucleus (Fig. 3), restored polySia expression
in both the mammalian and the bacterial cell system (Fig. 5,
A and C). The low polySia signal observed in
cells transfected with
BC3 corresponds to low expression of the
protein (Fig. 5, B and D). While
BC1 is
expressed at the level of the wild-type enzyme, the expression level of
BC3 is drastically reduced, in LEC29.Lec32 (Fig. 5B) and
E. coli (Fig. 5D) cells, indicating that deletion of BC3 interferes with expression and/or stability of the mutant protein. In contrast, cells transfected with the deletion mutants
BC2 and
BC2PA or the insertion mutant Ins-BC2
remained polySia-negative, despite stable expression of the proteins in
E. coli and, with the exception of Ins-BC2, also in
LEC29.Lec32. Because loss of activity in E. coli cannot be
solely due to the deletion of an NLS (see Fig. 3), this data suggest
that BC2 contains elements that are required for enzymatic
activity.

View larger version (53K):
[in this window]
[in a new window]
|
Fig. 5.
In vivo analysis of wild-type and
mutant murine CMP-Neu5Ac-syn synthetase activity. Wild-type and
mutant constructs were transiently expressed in LEC29.Lec32 cells
(A and B) and in E. coli EV5
(C and D). Mock transfections (Ø) were carried
out with the empty vectors pcDNA3 (A and B)
or pTrc99A (C and D). Whole cell lysates were
separated by 7% (A) or 10% SDS-PAGE (C), and
the expression of polySia was monitored by Western blot analysis using
mAb 735 (A and C). Specificity of the
anti-polySia mAb was controlled in a second aliquot of the cell lysates
by endoNE treatment prior to SDS-PAGE analysis (endoNE+).
Expression levels of the recombinant proteins were analyzed by 12%
SDS-PAGE followed by Western blot analysis using anti-Flag mAb M5
(B and D). The intracellular localization of the
mutants is indicated in the top row ("n," nucleus;
"c," cytoplasm, compare Figs. 3 and 4). Single amino
acids important for enzymatic activity are marked with an asterics in
the wild-type amino acid stretch given on the top of the figure. BC2 is
highlighted by a gray box.
|
|
To test for this possibility mutants harboring double and single amino
acid exchanges were analyzed for enzymatic activity as described. As
shown in Fig. 5, B and D, all protein variants were stably expressed in mammalian and bacterial cells. Simultaneous mutation of two basic amino acids, which kept CMP-Neu5Ac-syn in the
cytoplasm (see K198A/R201A and R199A/R202A in Fig. 4) led to a loss of
enzymatic activity only in the mutant R199A/R202A (Fig. 5, A
and C). The double mutant K198A/R201A was fully active and
consistent with this observation, and the single site mutants K198A and
R201A were, likewise, cytoplasmic but active. In contrast, the
cytoplasmic mutant R199A, as well as the predominantly nuclear mutant
R202A, showed drastically reduced synthetase activity. Whereas all
basic residues of BC2 are important for nuclear localization, Arg199 and Arg202 in addition are crucial for
enzymatic activity.
Helix-breaking proline residues found N-terminal (Pro196)
and in the middle (Pro200) of BC2 are not involved in
either nuclear transport (Fig. 4, H and I) nor
catalytic function of CMP-Neu5Ac-syn (Fig. 5, A and C). Similarly, replacement of Asp204 with
alanine had no deleterious effect on either function (see mutant
D204A), while mutant Q203A, although correctly located in the nucleus,
showed drastically reduced activity in both mammalian and bacterial
cells. These findings suggest that Gln203 is involved in
the catalytic function of CMP-Neu5Ac-syn. The combined data demonstrate
that synthetase activity and nuclear transport are independent
properties of the murine CMP-Neu5Ac-syn, but they are located in the
same domain, and thus they may both be inactivated by changes in
certain amino acids they share in common.
Arg202 and Gln203 Are Evolutionary
Conserved Amino Acid Residues--
The functional importance of
Gln203, which is not part of BC2, prompted us to analyze
amino acids at related positions in other CMP-Neu5Ac-syn sequences. The
alignment in Fig. 6A shows a
comparison of bacterial CMP-sialic acid synthetases (19-24), murine
CMP-Neu5Ac-syn (25), and the recently cloned rainbow trout CMP-Kdn-syn,
which exhibits a similar affinity for Neu5Ac and Kdn (26).
Additionally, the sequences of putative CMP-sialic acid synthetases
that have been identified based on homology were aligned in Fig.
6B. Amino acid residues that comprise BC2 in the murine
sequence are shaded in gray. The alignment reveals that
Arg202 (part of BC2) and Gln203 represent
highly conserved positions (open boxes), although a conservative substitution of glutamine by asparagine occurs in E. coli and Legionella pneumoniae, and cysteine
substitutes arginine in the L. pneumoniae enzyme.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 6.
A multi-sequence alignment has been carried
out with confirmed (A) and predicted
(B) CMP-sialic acid synthetases to display maximum
homology. The segment containing BC2 (shaded box) in
the murine CMP-Neu5Ac-syn is shown. The alignment clearly demonstrates
that Arg202 and Gln203 in the murine enzyme
represent highly conserved residues (open boxes).
Numbers indicate the first amino acid residue of the
displayed sequences. Accession numbers are given on the
right (*, SwissProt data base; , European Molecular
Biology Laboratory data base; , GenBankTM data
base).
|
|
Evolutionary Conserved Residues in BC2 Are Important for Enzymatic
Activity--
Our finding that Arg202 is part of the
active site in murine CMP-Neu5Ac-syn is in excellent agreement with
crystal structure data recently obtained for the NmB
CMP-Neu5Ac-syn (45). In the NmB enzyme Arg165,
which corresponds to Arg202 in the murine enzyme,
participates in Neu5Ac binding, providing an explanation for the
dramatic drop in activity seen for murine mutant R202A (Fig. 5,
A and C). However, the structural data do not
contain information about the functional relevance of the neighboring
glutamine residue (Gln166 in NmB;
Gln203 in mouse). To investigate this in more detail, both
Arg165 and Gln166 in the NmB enzyme
were mutated to alanine, resulting in the mutants NmB R165A
and NmB Q166A (Table IIC), respectively. Activity was tested
by complementation in E. coli EV5 as described (Fig.
7). As expected from the crystal
structure, no activity was found for NmB R165A (Fig.
7A). The respective murine mutant R202A exhibited low but
detectable activity in EV5 (see Fig. 5C). Moreover, the activity in mutant NmB Q166A, like the corresponding murine
mutant Q203A (Fig. 5C), was strongly reduced (Fig.
7A). Both proteins were expressed at the level of the
wild-type enzyme (Fig. 7B), indicating that catalytic
function, but not protein stability, is impaired in the mutant
proteins. These data confirm the essential function of this conserved
amino acid pair and strongly suggest that Arg202 in the
murine enzyme, which is analogous to Arg165 in the
NmB enzyme, participates in substrate binding. The
functional role of the conserved glutamine residue is not clear, but
the structural data obtained for the NmB enzyme (45) suggest
that this conserved glutamine residue is involved in the quaternary organization of CMP-Neu5Ac-syn.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 7.
In vivo analysis of enzymatic
activity of N. meningitidis serogroup B
CMP-Neu5Ac-syn. Wild-type and mutant constructs were transiently
expressed in E. coli EV5 (A and B) and
compared with mock-transfection with the empty vector pTrc99A (Ø).
Whole cell lysates were separated by 10% (A) or 12%
SDS-PAGE (B), and polySia expression was monitored by
Western blot analysis using anti-polySia mAb 735 (A).
Specificity of the polySia staining was controlled in a second aliquot
of the cell lysates by endoNE treatment prior to SDS-PAGE analysis
(endoNE+). Expression levels of recombinant proteins were
analyzed by 12% SDS-PAGE and Western blot analysis using anti-FLAG mAb
M5 (B).
|
|
 |
DISCUSSION |
Isolation of the murine CMP-Neu5Ac-syn cDNA and visualization
of the epitope-tagged recombinant protein in mammalian cells (25)
corroborated earlier reports that CMP-Neu5Ac-syn is a nuclear protein
in different vertebrate cells (for review, see Refs. 18; 46).
Translocation in the nucleus often depends on the existence of an NLS
sequence, which in the case of canonical NLSs are short stretches of
basic amino acids that mediate nuclear import of mature proteins. Apart
from the well defined NLSs found in SV40 large T antigen and
nucleoplasmin (33, 47), a variety of NLS have been identified (for
review, see Refs. 27; 31). Although no strictly conserved consensus
sequence has been delineated so far, variations of the four-pattern
motif K-K/R-X-K are available for data base searches
(PSORTII; Refs. 39, 40, and 48). However, the existence of a putative
NLS must still be verified experimentally.
Three NLS-like motifs previously identified in the primary sequence of
the murine CMP-Neu5Ac-syn were investigated for function in this study
(25). Initially the capability of each basic cluster to target eGFP
into the cell nucleus was analyzed (Fig. 2). This technique has been
employed successfully to study NLS sequences from other
nuclear-localized proteins (e.g. Stat5b (49), diacylglycerol kinase-
(50), and Ring3 (42)). Furthermore, the importance of
individual basic clusters for the nuclear import of CMP-Neu5Ac-syn was
tested with deletion mutants
BC1-
BC3 (Fig. 3).
The most C-terminal basic cluster BC3 was unable to significantly alter
the localization of eGFP (Fig. 2), and deletion of BC3 had no
deleterious effect on nuclear import of murine CMP-Neu5Ac-syn (Fig. 3).
Both findings demonstrate that BC3 is not a functional NLS. In
addition, BC3 seems not to contain elements that are required for
catalytic activity. The low expression levels of this mutant protein in
transfection experiments, however, suggest that this amino acid stretch
may be important for the folding and/or stability of the CMP-
Neu5Ac-syn.
The most N-terminal basic cluster BC1 is sufficient to direct eGFP to
the nuclear compartment (Fig. 2), but it is not necessary for nuclear
import of the parent protein under the experimental conditions used in
this study (Fig. 3). It may be that BC1 supports nuclear transport
physiologically, for example by improving the kinetics of the transport
process. There are examples where an enhancement in nuclear transport
is observed if two or more NLS are present in a given protein (51, 52).
Alternatively, BC1 could be masked in the native CMP-Neu5Ac-syn by
inter- or intramolecular interactions and thus not be accessible to
transport factors (53). Secondary structure predictions argue against
this latter hypothesis and suggest BC1 to be a flexible hydrophilic
region, most likely located at the surface of the protein. In line with
this we found that the stability of a bacterial expressed recombinant
CMP-Neu5Ac-syn is enhanced if 38 amino acids are deleted from the N
terminus. This truncation, which includes BC1, does not affect the
activity of the recombinant
protein.3 So far, our data
are not sufficient to elucidate the role of BC1 in the native protein.
BC2 is sufficient to target eGFP to the nuclear compartment and, in
addition, is the dominant NLS in murine CMP-Neu5Ac-syn. Deletion of the
five amino acid residues that form BC2 (K198RPRR) was
sufficient to retain the enzyme in the cytoplasm. Using site-directed
mutagenesis the basic amino acids Lys198,
Arg199, and Arg201 were shown to be essential
for the formation of the functional NLS. Isolated replacement of these
positions by alanine completely abolished nuclear transport (see Fig.
4, D-F). Arg202 is important for optimal NLS
function. The effect on transport observed in the mutant R202A was
small but clearly visible in repeated experiments (see Fig.
4G). Pro200, despite being part of BC2, is not
required for the formation of a functional NLS. Additional experiments
are required to determine whether Pro200 is of importance
for the spatial geometry of the NLS. At this point we are also unable
to judge the importance of Pro196 (see BC2PA).
Helix-breaking proline residues often precede an NLS and augment activity (for review, see Refs. 27 and 31). Such an effect was not
observed in this study, but may be of importance under physiological
conditions. Finally, variations in the highly conserved C-terminal-flanking amino acid residues of BC2 (mutants Q203A and
D204A) are irrelevant for the nuclear transport. Because neither the N-
nor the C-terminal ends of BC2 are involved in nuclear transport of
murine CMP-Neu5Ac-syn, the active NLS was determined to be
K198RXRR.
This motif fits well with the four-residue motif K-K/R-X-K
used in data base searches (PSORT II; Refs. 39 and 40) and originally
suggested by Chelsky (K-R/K-X-R/K; Ref. 48). Interacting
partners recognizing BC2 and the transport pathway for nuclear import
of the protein remain to be elucidated.
Expression of active murine CMP-Neu5Ac-syn in bacteria has already
suggested that CMP-Neu5Ac-syn activity from animal cells is not
dependent on nuclear localization (Ref. 25 and this paper). To
determine connections between nuclear localization and synthetase activity, mutants generated in this study were tested for their ability
to complement two CMP-Neu5Ac-syn-deficient mutants, CHO LEC29.Lec32
cells (36) and E. coli EV5 (43). Enzymatic activity and
protein expression were found to correlate directly in bacteria and
mammalian cells for the wild-type and mutant CMP-Neu5Ac-syn. Importantly, activity in eukaryotic cells seems not to be dependent on
nuclear localization, since the cytoplasmic mutants K198A and R201A
restored polySia biosynthesis. Furthermore, the fact that Arg199 and Arg202 are involved in both nuclear
transport and catalytic activity of CMP-Neu5Ac-syn suggests that a
functional NLS is also required for optimal catalysis. BC2 may contain
part of the active site of the enzyme or, perhaps more likely, is
important for maintaining the structure of the active site. The results
are supported by the comparison of various known CMP-Neu5Ac-syn
sequences (Fig. 6). The alignment revealed no significant conservation
for BC2 but identified Arg202 and Gln203 as
highly conserved residues. This is in line with crystal structure data
recently obtained for the NmB enzyme (45), which show that Arg165 (corresponding to Arg202 in the murine
enzyme) is part of the CMP-Neu5Ac binding pocket and of the
dimerization domain. As expected from this central function, the
exchange R165A completely abolished catalytic activity in the
NmB enzyme. It is most likely that Arg202 has an
identical function in the murine enzyme. It was, however, surprising to
find that the negatively charged Glu162, also part of the
Neu5Ac binding pocket in the NmB enzyme, corresponds to the
positively charged Arg199 in the murine enzyme.
Mutation of the second highly conserved residue, Gln203 in
mouse and Gln166 in NmB, to alanine was followed
by a drastically reduced functional activity (Figs. 5 and 7). According
to the existing three-dimensional data this position does not
participate in substrate binding but seems to be required for the
quaternary organization of the protein (45). A lack of quaternary
organization in mutants may worsen the overall kinetics of their
reactions thus leading to the decreased enzyme activity.
Several suggestions have been made to explain the unusual subcellular
localization of CMP-Neu5Ac-syn. (i) The nuclear environment may be a
prerequisite for enzymatic activity. (ii) The CTP concentration may be
higher in the cell nucleus. (iii) Production of CMP-Neu5Ac in the
nucleus may protect the nucleotide sugar from subsequent modifications
by cytoplasmic enzymes, such as the CMP-Neu5Ac hydroxylase (54, 55).
(iv) CMP-Neu5Ac is an allosteric inhibitor of UDP-GlcNAc 2-epimerase/kinase. This enzyme, which is localized in the cytoplasm, initiates the synthesis of sialic acids. Sequestration of CMP-Neu5Ac may be necessary to prevent early inactivation of UDP-GlcNAc
2-epimerase/kinase. (v) CMP-Neu5Ac may possibly be required for
sialyltransferases localized in the nucleus. Sialyltransferase activity
associated with rat liver nuclei has been reported that may be critical
for the regular function of various nuclear proteins, which never transit the Golgi apparatus (56, 57). Our data show that cytoplasmic forms of the murine CMP-Neu5Ac-syn are active in mammalian cells, thus
nuclear localization cannot be a prerequisite for enzymatic activity
and the CTP concentration in the cytoplasm is at least sufficient for
the functionality of the enzyme. Moreover, trials to discriminate
between cytosolic and nuclear CTP pools failed (58). On the other hand,
Vionnet et al. (46) demonstrated DNA- binding for the
purified bovine CMP-Neu5Ac-syn. The data presented in this study, as
well as earlier data describing the unusual localization of
CMP-Neu5Ac-syn in the nuclear compartment, allow us to speculate that
CMP-Neu5Ac-syn or its product may have a second cellular function.
Initial experiments have been carried out in our laboratory toward
understanding the physiological relevance of the nuclear localization,
but at the cell culture level no noticeable differences were found
between LEC29.Lec32 cells transfected with either nuclear or
cytoplasmic forms of CMP-Neu5Ac-syn. We are currently investigating
whether the ratio between N-acetyl- and
N-glycolylneuraminic acid varies with the subcellular
localization of the CMP-Neu5Ac-syn. Most important, a transgenic mouse
model shall soon be available, in which cytoplasmic forms substitute endogenous CMP-Neu5Ac-syn. This model should provide a new basis for
studies aimed at enlightening the functional role of CMP-Neu5Ac-syn in
the cell nucleus.
 |
ACKNOWLEDGEMENTS |
We thank Dres. G. Tiralongo, A. Dickmanns,
and Dr. P. Stanley for critical remarks on the manuscript, Dr. M. Bredt
for help with the fluorescence microscope, and Dr. E. Vimr for kindly
providing E. coli strain EV5. Prof. D. Bitter-Suermann is
acknowledged for continuous support.
 |
FOOTNOTES |
*
This work was supported by grants from the Deutsche
Forschungsgemeinschaft (GE 801/5-1) and by a Ph.D. grant from the
Hans-Böckler-Stiftung (to A. K. Münster).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Inst. für
Physiologische Chemie/Proteinstruktur, Medizinische Hochschule
Hannover, Carl-Neuberg-Str. 1, 30625 Hannover, Germany. Tel.:
49-511-532-9802; Fax: 49-511-532-3956; E-mail:
gerardy-schahn.rita@mh-hannover.de.
Published, JBC Papers in Press, March 13, 2002, DOI 10.1074/jbc.M201093200
2
The position of the amino acid in the primary
sequence is indicated as a superscript in the top right hand corner
(e.g. K198).
3
A. K. Münster and R. Gerardy-Schahn,
unpublished observation.
 |
ABBREVIATIONS |
The abbreviations used are:
Neu5Ac, 5-N-acetylneuraminic acid;
BC, basic cluster;
CHO chinese
hamster ovary, CMP-Neu5Ac, cytidine 5'-monophosphate
N-acetylneuraminic acid;
CMP-Neu5Ac-syn, CMP-Neu5Ac
synthetase;
eGFP, enhanced green fluorescent protein;
endoNE, endoneuraminidase NE;
mAb, monoclonal antibody;
NLS, nuclear
localization signal;
polySia, polysialic acid.
 |
REFERENCES |
| 1.
|
Schauer, R.
(2000)
Glycoconj. J.
17,
485-499[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Kelm, S.,
and Schauer, R.
(1997)
Int. Rev. Cytol.
175,
137-240[Medline]
[Order article via Infotrieve]
|
| 3.
|
Munday, J.,
Floyd, H.,
and Crocker, P. R.
(1999)
J. Leukoc. Biol.
66,
705-711[Abstract]
|
| 4.
|
Dell, A.,
Morris, H. R.,
Easton, R. L.,
Patankar, M.,
and Clark, G. F.
(1999)
Biochim. Biophys. Acta
1473,
196-205[Medline]
[Order article via Infotrieve]
|
| 5.
|
Cremer, H.,
Chazal, G.,
Lledo, P. M.,
Rougon, G.,
Montaron, M. F.,
Mayo, W., Le,
Moal, M.,
and Abrous, D. N.
(2000)
Int. J. Dev. Neurosci.
18,
213-220[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Bruses, J. L.,
and Rutishauser, U.
(2001)
Biochimie (Paris)
83,
635-643
|
| 7.
|
Eckhardt, M.,
Bukalo, O.,
Chazal, G.,
Wang, L.,
Goridis, C.,
Schachner, M.,
Gerardy-Schahn, R.,
Cremer, H.,
and Dityatev, A.
(2000)
J. Neurosci.
20,
5234-5244[Abstract/Free Full Text]
|
| 8.
|
Bratosin, D.,
Mazurier, J.,
Debray, H.,
Lecocq, M.,
Boilly, B.,
Alonso, C.,
Moisei, M.,
Motas, C.,
and Montreuil, J.
(1995)
Glycoconj. J.
12,
258-267[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Inoue, S.,
and Inoue, Y.
(2001)
J. Biol. Chem.
276,
31863-31870[Abstract/Free Full Text]
|
| 10.
|
Glüer, S.,
Schelp, C.,
Madry, N.,
von Schweinitz, D.,
Eckhardt, M.,
and Gerardy-Schahn, R.
(1998)
Br. J. Cancer
78,
106-110[Medline]
[Order article via Infotrieve]
|
| 11.
|
Jimbo, T.,
Nakayama, J.,
Akahane, K.,
and Fukuda, M.
(2001)
Int. J. Cancer
94,
192-199[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Daniel, L.,
Trouillas, J.,
Renaud, W.,
Chevallier, P.,
Gouvernet, J.,
Rougon, G.,
and Figarella-Branger, D.
(2000)
Cancer Res.
60,
80-85[Abstract/Free Full Text]
|
| 13.
|
Jann, B.,
and Jann, K.
(1990)
Curr. Top. Microbiol. Immunol.
150,
19-42[Medline]
[Order article via Infotrieve]
|
| 14.
|
Moran, A. P.,
Prendergast, M. M.,
and Appelmelk, B. J.
(1996)
FEMS Immunol. Med. Microbiol.
16,
105-115[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Hood, D. W.,
Makepeace, K.,
Deadman, M. E.,
Rest, R. F.,
Thibault, P.,
Martin, A.,
Richards, J. C.,
and Moxon, E. R.
(1999)
Mol. Microbiol.
33,
679-692[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Mühlenhoff, M.,
Eckhardt, M.,
and Gerardy-Schahn, R.
(1998)
Curr. Opin. Struct. Biol.
8,
558-564[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Vogel, U.,
Claus, H.,
Heinze, G.,
and Frosch, M.
(1999)
Infect. Immun.
67,
954-957[Abstract/Free Full Text]
|
| 18.
|
Kean, E. L.
(1991)
Glycobiology
1,
441-447[Abstract/Free Full Text]
|
| 19.
|
Tullius, M. V.,
Munson, R. S. J.,
Wang, J.,
and Gibson, B. W.
(1996)
J. Biol. Chem.
271,
15373-15380[Abstract/Free Full Text]
|
| 20.
|
Zapata, G.,
Vann, W. F.,
Aaronson, W.,
Lewis, M. S.,
and Moos, M.
(1989)
J. Biol. Chem.
264,
14769-14774[Abstract/Free Full Text]
|
| 21.
|
Haft, R. F.,
Wessels, M. R.,
Mebane, M. F.,
Conaty, N.,
and Rubens, C. E.
(1996)
Mol. Microbiol.
19,
555-563[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Edwards, U.,
and Frosch, M.
(1992)
FEMS Microbiol. Lett.
75,
161-166[Medline]
[Order article via Infotrieve]
|
| 23.
|
Guerry, P.,
Doig, P.,
Alm, R. A.,
Burr, D. H.,
Kinsella, N.,
and Trust, T. J.
(1996)
Mol. Microbiol.
19,
369-378[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Lüneberg, E.,
Zetzmann, N.,
Alber, D.,
Knirel, Y. A.,
Kooistra, O.,
Zähringer, U.,
and Frosch, M.
(2000)
Int. J. Med. Microbiol.
290,
37-49[Medline]
[Order article via Infotrieve]
|
| 25.
|
Münster, A. K.,
Eckhardt, M.,
Potvin, B.,
Mühlenhoff, M.,
Stanley, P.,
and Gerardy-Schahn, R.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
9140-9145[Abstract/Free Full Text]
|
| 26.
|
Nakata, D.,
Münster, A. K.,
Gerardy-Schahn, R.,
Aoki, N.,
Matsuda, T.,
and Kitajima, K.
(2001)
Glycobiology
11,
685-692[Abstract/Free Full Text]
|
| 27.
|
Mattaj, I. W.,
and Englmeier, L.
(1998)
Annu. Rev. Biochem.
67,
265-306[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Görlich, D.,
and Kutay, U.
(1999)
Annu. Rev. Cell Dev. Biol.
15,
607-660[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Yoneda, Y.,
Hieda, M.,
Nagoshi, E.,
and Miyamoto, Y.
(1999)
Cell Struct. Funct.
24,
425-433[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Görlich, D.,
and Mattaj, I. W.
(1996)
Science
271,
1513-1518[Abstract]
|
| 31.
|
Jans, D. A.,
and Hübner, S.
(1996)
Physiol. Rev.
76,
651-685[Abstract/Free Full Text]
|
| 32.
|
Garcia-Bustos, J.,
Heitman, J.,
and Hall, M. N.
(1991)
Biochim. Biophys. Acta
1071,
83-101[Medline]
[Order article via Infotrieve]
|
| 33.
|
Kalderon, D.,
Richardson, W. D.,
Markham, A. F.,
and Smith, A. E.
(1984)
Nature
311,
33-38[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Gerardy-Schahn, R.,
Bethe, A.,
Brennecke, T.,
Mühlenhoff, M.,
Eckhardt, M.,
Ziesing, S.,
Lottspeich, F.,
and Frosch, M.
(1995)
Mol. Microbiol.
16,
441-450[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Frosch, M.,
Gorgen, I.,
Boulnois, G. J.,
Timmis, K. N.,
and Bitter-Suermann, D.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
1194-1198[Abstract/Free Full Text]
|
| 36.
|
Potvin, B.,
Raju, T. S.,
and Stanley, P.
(1995)
J. Biol. Chem.
270,
30415-30421[Abstract/Free Full Text]
|
| 37.
|
Vimr, E. R.,
and Troy, F. A.
(1985)
J. Bacteriol.
164,
854-860[Abstract/Free Full Text]
|
| 38.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Horton, P.,
and Nakai, K.
(1996)
Proc. Int. Conf. Intell. Syst. Mol. Biol.
4,
109-115[Medline]
[Order article via Infotrieve]
|
| 40.
|
Horton, P.,
and Nakai, K.
(1997)
Proc. Int. Conf. Intell. Syst. Mol. Biol.
5,
147-152[Medline]
[Order article via Infotrieve]
|
| 41.
|
Cokol, M.,
Nair, R.,
and Rost, B.
(2000)
EMBO Rep.
1,
411-415[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Guo, N.,
Faller, D. V.,
and Denis, G. V.
(2000)
J. Cell Sci.
113,
3085-3091[Abstract]
|
| 43.
|
Vimr, E. R.,
Aaronson, W.,
and Silver, R. P.
(1989)
J. Bacteriol.
171,
1106-1117[Abstract/Free Full Text]
|
| 44.
|
Bliss, J. M.,
and Silver, R. P.
(1996)
Mol. Microbiol.
21,
221-231[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Mosimann, S. C.,
Gilbert, M.,
Dombroswki, D., To, R.,
Wakarchuk, W.,
and Strynadka, N. C.
(2001)
J. Biol. Chem.
276,
8190-8196[Abstract/Free Full Text]
|
| 46.
|
Vionnet, J.,
Concepcion, N.,
Warner, T.,
Zapata, G.,
Hanover, J.,
and Vann, W. F.
(1999)
Glycobiology
9,
481-487[Abstract/Free Full Text]
|
| 47.
|
Robbins, J.,
Dilworth, S. M.,
Laskey, R. A.,
and Dingwall, C.
(1991)
Cell
64,
615-623[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Chelsky, D.,
Ralph, R.,
and Jonak, G.
(1989)
Mol. Cell. Biol.
9,
2487-2492[Abstract/Free Full Text]
|
| 49.
|
Herrington, J.,
Rui, L.,
Luo, G., Yu-,
Lee, L. Y.,
and Carter-Su, C.
(1999)
J. Biol. Chem.
274,
5138-5145[Abstract/Free Full Text]
|
| 50.
|
Topham, M. K.,
Bunting, M.,
Zimmerman, G. A.,
McIntyre, T. M.,
Blackshear, P. J.,
and Prescott, S. M.
(1998)
Nature
394,
697-700[CrossRef][Medline]
[Order article via Infotrieve]
|
| 51.
|
Richardson, W. D.,
Roberts, B. L.,
and Smith, A. E.
(1986)
Cell
44,
77-85[CrossRef][Medline]
[Order article via Infotrieve]
|
| 52.
|
Shaulsky, G.,
Goldfinger, N.,
Ben Ze'ev, A.,
and Rotter, V.
(1990)
Mol. Cell. Biol.
10,
6565-6577[Abstract/Free Full Text]
|
| 53.
|
Moreland, R. B.,
Nam, H. G.,
Hereford, L. M.,
and Fried, H. M.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
6561-6565[Abstract/Free Full Text]
|
| 54.
|
Shaw, L.,
and Schauer, R.
(1988)
Biol. Chem. Hoppe-Seyler
369,
477-486[Medline]
[Order article via Infotrieve]
|
| 55.
|
Malykh, Y. N.,
Krisch, B.,
Shaw, L.,
Warner, T. G.,
Sinicropi, D.,
Smith, R.,
Chang, J.,
and Schauer, R.
(2001)
Eur. J. Cell Biol.
80,
48-58[CrossRef][Medline]
[Order article via Infotrieve]
|
| 56.
|
Emig, S.,
Schmalz, D.,
Shakibaei, M.,
and Buchner, K.
(1995)
J. Biol. Chem.
270,
13787-13793[Abstract/Free Full Text]
|
| 57.
|
Richard, M.,
Martin, A.,
and Louisot, P.
(1975)
Biochem. Biophys. Res. Commun.
64,
109-114[Medline]
[Order article via Infotrieve]
|
| 58.
|
Pels, R. W.,
Overdijk, B.,
Van den Eijnden, D. H.,
and Ferwerda, W.
(1993)
Biochem. J.
293,
207-213[Medline]
|